Literature DB >> 3512751

Kinetics of macrophage recruitment and turnover in peritoneal inflammatory exudates induced by Salmonella or thioglycollate broth.

K E Hopper.   

Abstract

Kinetics of peritoneal macrophage turnover during infection of mice with Salmonella enteritidis or following injection with thioglycollate broth or other peritoneal stimulants has been studied. Single intravenous injections of tritiated thymidine were given and the cells were examined by autoradiography. Maximum labelling of small adherent peritoneal macrophages occurred when 3H-thymidine was given 1 d after Salmonella and the cells were harvested 1 d later. Labelled cells decreased at later times despite maintenance of high numbers of macrophages in the exudates. Results from experiments in which labelled peritoneal cells were reinjected indicated that small, monocyte-enriched, labelled cells were not the major source of the large macrophages. Similar labelling at 2 d was observed using heat-killed Corynebacterium parvum or lipopolysaccharide (LPS) as ip stimulants. Following injection of thioglycollate broth, labelled peritoneal macrophages were only detectable if 3H-thymidine was given before the stimulant. These labelled cells remained longer in the peritoneal cavity. Labelling of and numbers of blood monocytes were consistent with the promotion of monocytopoiesis by Salmonella but not by thioglycollate. The response to thioglycollate but not Salmonella was dependent on the age of the mice. Animals injected with thioglycollate 1 d before Salmonella also had decreased resistance to bacteria and low numbers of labelled peritoneal macrophages. We propose that thioglycollate may recruit from a subset of preformed monocytes and temporarily block monocytopoiesis or macrophage bactericidal activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3512751     DOI: 10.1002/jlb.39.4.435

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  Binding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophages.

Authors:  Zong Liang Chang; Dale Netski; Peter Thorkildson; Thomas R Kozel
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis.

Authors:  Norihiko Takeda; Ellen L O'Dea; Andrew Doedens; Jung-whan Kim; Alexander Weidemann; Christian Stockmann; Masataka Asagiri; M Celeste Simon; Alexander Hoffmann; Randall S Johnson
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

3.  Macrophage activation reduces mobilization of arachidonic acid by guinea-pig and rat peritoneal macrophages in vitro.

Authors:  W H Lim; A G Stewart
Journal:  Agents Actions       Date:  1990-11

4.  Specific calcineurin targeting in macrophages confers resistance to inflammation via MKP-1 and p38.

Authors:  Amelia Escolano; Sara Martínez-Martínez; Arántzazu Alfranca; Katia Urso; Helena M Izquierdo; Mario Delgado; Francisco Martín; Guadalupe Sabio; David Sancho; Pablo Gómez-del Arco; Juan Miguel Redondo
Journal:  EMBO J       Date:  2014-03-03       Impact factor: 11.598

5.  ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway.

Authors:  Nicholas S Wilson; Becky Yang; Adriana Baz Morelli; Sandra Koernig; Annie Yang; Stefanie Loeser; Denise Airey; Larissa Provan; Phil Hass; Hal Braley; Suzana Couto; Debbie Drane; Jeff Boyle; Gabrielle T Belz; Avi Ashkenazi; Eugene Maraskovsky
Journal:  Immunol Cell Biol       Date:  2011-09-06       Impact factor: 5.126

6.  Spontaneous formation of IpaB ion channels in host cell membranes reveals how Shigella induces pyroptosis in macrophages.

Authors:  L Senerovic; S P Tsunoda; C Goosmann; V Brinkmann; A Zychlinsky; F Meissner; M Kolbe
Journal:  Cell Death Dis       Date:  2012-09-06       Impact factor: 8.469

7.  Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation.

Authors:  Luke C Davies; Marcela Rosas; Stephen J Jenkins; Chia-Te Liao; Martin J Scurr; Frank Brombacher; Donald J Fraser; Judith E Allen; Simon A Jones; Philip R Taylor
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  Mesenchymal stem cells do not prevent antibody responses against human α-L-iduronidase when used to treat mucopolysaccharidosis type I.

Authors:  Priscila Keiko Matsumoto Martin; Roberta Sessa Stilhano; Vivian Yochiko Samoto; Christina Maeda Takiya; Giovani Bravin Peres; Yara Maria Correa da Silva Michelacci; Flavia Helena da Silva; Vanessa Gonçalves Pereira; Vânia D'Almeida; Fabio Luiz Navarro Marques; Andreia Hanada Otake; Roger Chammas; Sang Won Han
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.